IL12B rs6887695 emerged as a potential pharmacogenetic marker associated with favorable ustekinumab outcomes; however, this exploratory and hypothesis-generating finding requires external validation in larger, independent cohorts before clinical application.
Ylenia Marino, M. Rottura, Claudia Ligresti et al.· Pharmaceuticals· 0 citations
DLSCT showed high concordance with MRI for several locoregional imaging features of rectal cancer, and may provide complementary information, particularly when MRI is contraindicated or inconclusive, but these findings do not establish equivalence to MRI or diagnostic accuracy against histopathology.
S. Mazziotti, Giorgio Ascenti, Tommaso D'Angelo et al.· Diagnostics· 0 citations
Upadacitinib was effective and well-tolerated in AT-experienced Crohn's disease, including patients with active EIMs, with induction benefit maintained through 6 months without novel safety signals.
B. Barberio, F. D'Amico, L. Laterza et al.· Alimentary Pharmacology and...· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.